A Study of SGN-CEACAM5C in Adults With Advanced Solid Tumors
for Colorectal Neoplasms
Sites in Aurora +20 more locations
Sponsor: Seagen, a wholly owned subsidiary of Pfizer
Sex: All·Age: 18+
Code: NCT06131840·Phase 1·Recruiting·Listed Nov 2023
Oncology Clinical Trials in Aurora, CO
As of August 2026, 200 paid clinical trials are recruiting for Oncology in Aurora, Colorado. Compensation typically covers time, travel, and study visits, and many studies also include study-related medical care at no cost.
Recruiting trial data synced daily from ClinicalTrials.gov. Last sync: .
Filter results
Filter results
203 clinical trials for Oncology
·Clear filters· Email me when a new oncology trial opens in Aurora, CO.
A Study of LY4050784 in Participants With Advanced or Metastatic Solid Tumors
for Metastatic Solid Tumor
Sites in Aurora, Denver +14 more locations
Sponsor: Eli Lilly and Company
Sex: All·Age: 18+
Code: NCT06561685·Phase 1·Recruiting·Listed Aug 2024
A Study of Tacabrutideg (BGB-16673) Compared to Investigator's Choice in Participants With Chronic Lymphocytic Leukemia or Small Lymphocytic Lymphoma Previously Exposed to Both Bruton Tyrosine Kinase (BTK) and B-cell Leukemia/Lymphoma 2 Protein (BCL2) Inhibitors
for CLL
Sites in Aurora +25 more locations
Sponsor: BeOne Medicines
Sex: All·Age: 18+
Code: NCT06846671·Phase 3·Recruiting·Listed Feb 2025
Study of Patritumab Deruxtecan in Participants With Gastrointestinal Cancers (MK-1022-011) (HERTHENA-PanTumor02)
for Gastrointestinal Cancer
Sites in Aurora +6 more locations
Sponsor: Merck Sharp & Dohme LLC
Sex: All·Age: 18+
Code: NCT06596694·Phase 1, Phase 2·Recruiting·Listed Sep 2024
A Study of CHS-114 (Tagmokitug) in Combination With Toripalimab and/or Other Treatments in Participants With Advanced Solid Tumors
for Metastatic Solid Tumor
Sites in Aurora +17 more locations
Sponsor: Coherus Oncology, Inc.
Sex: All·Age: 18+
Code: NCT06657144·Phase 1·Recruiting·Listed Oct 2024
Study of Elironrasib and Daraxonrasib as Monotherapies and Combination Therapy in Participants With Advanced KRAS G12C Mutant Solid Tumors
for Non-Small Cell Lung Cancer (NSCLC)
Drug: daraxonrasib
Sites in Aurora +19 more locations
Sponsor: Revolution Medicines, Inc.
Sex: All·Age: 18+
Code: NCT06128551·Phase 1, Phase 2·Recruiting·Listed Nov 2023
A Study of JNJ-88549968 for the Treatment of Calreticulin (CALR)-Mutated Myeloproliferative Neoplasms
for Neoplasms
Sites in Aurora +12 more locations
Sponsor: Janssen Research & Development, LLC
Sex: All·Age: 18+
Code: NCT06150157·Phase 1·Recruiting·Listed Nov 2023
Sonocloud-9 in Association With Carboplatin Versus Standard-of-Care Chemotherapies (CCNU or TMZ) in Recurrent GBM
for Glioblastoma
Sites in Aurora +15 more locations
Sponsor: CarThera
Sex: All·Age: 18+
Code: NCT05902169·Phase 3·Recruiting·Listed Jun 2023
A Phase 1b/2a Study of Pocenbrodib as Monotherapy and in Combination With Darolutamide in Participants With mCRPC
for mCRPC (Metastatic Castration-resistant Prostate Cancer)
Sites in Aurora +18 more locations
Sponsor: Pathos AI, Inc.
Sex: Male·Age: 18+
Code: NCT06785636·Phase 1, Phase 2·Recruiting·Listed Jan 2025
Substudy 01A: Zilovertamab Vedotin in Pediatric and Young Adult Participants With Hematologic Malignancies or Solid Tumors (MK-9999-01A/LIGHTBEAM-U01)
for B-cell Acute Lymphoblastic Leukemia
Sites in Aurora +16 more locations
Sponsor: Merck Sharp & Dohme LLC
Sex: All·Age: 6 Months - 25
Code: NCT06395103·Phase 1, Phase 2·Recruiting·Listed May 2024
A Study of the Efficacy and Safety of Lisocabtagene Maraleucel (Liso-cel) as First-Line Therapy in Adults With Transplant-Ineligible Primary Central Nervous System Lymphoma
for Lymphoma
Sites in Aurora +13 more locations
Sponsor: Juno Therapeutics, Inc., a Bristol-Myers Squibb Company
Sex: All·Age: 18+
Code: NCT07015242·Phase 2·Recruiting·Listed Jun 2025
A Study of Patritumab Deruxtecan in Pediatric Participants With Relapsed or Refractory Solid Tumors (MK-9999-01C/LIGHTBEAM-U01)
for Malignant Neoplasm
Sites in Aurora +16 more locations
Sponsor: Merck Sharp & Dohme LLC
Sex: All·Age: 1 Month - 17
Code: NCT06941272·Phase 1, Phase 2·Recruiting·Listed Apr 2025
Study to Investigate Lifileucel Regimen Plus Pembrolizumab Compared With Pembrolizumab Alone in Participants With Untreated Advanced Melanoma.
for Metastatic Melanoma
Drug: Lifileucel
Sites in Aurora +17 more locations
Sponsor: Iovance Biotherapeutics, Inc.
Sex: All·Age: 18 - 70
Code: NCT05727904·Phase 3·Recruiting·Listed Feb 2023
A Phase 1 Study of BMS-986500 as Monotherapy or Combination Therapy in Advanced Solid Tumors
for Advanced Solid Tumor
Sites in Aurora +14 more locations
Sponsor: Bristol-Myers Squibb
Sex: All·Age: 18+
Code: NCT06997029·Phase 1·Recruiting·Listed May 2025
A Study to Investigate Safety and Effectiveness of CRN09682 in Participants With SST2-Expressing NENs and Other Solid Tumors
for SST2-positive Neuroendocrine Neoplasms
Sites in Aurora, Denver +21 more locations
Sponsor: Crinetics Pharmaceuticals Inc.
Sex: All·Age: 18+
Code: NCT07129252·Phase 1, Phase 2·Recruiting·Listed Aug 2025
A Clinical Study of MK-2870 Alone or With Other Treatments to Treat Gastrointestinal Cancers (MK-9999-02A)
for Colorectal Cancer
Sites in Aurora +11 more locations
Sponsor: Merck Sharp & Dohme LLC
Sex: All·Age: 18+
Code: NCT06428409·Phase 1, Phase 2·Recruiting·Listed May 2024
Study of DISC-0974 (RALLY-MF) in Participants With Myelofibrosis or Myelodysplastic Syndrome and Anemia
for Myelofibrosis
Sites in Aurora +23 more locations
Sponsor: Disc Medicine, Inc
Sex: All·Age: 18+
Code: NCT05320198·Phase 1, Phase 2·Recruiting·Listed Apr 2022
Long-Term Safety of Lutetium (177Lu) Vipivotide Tetraxetan in Participants With Prostate Cancer
for Prostate Cancer
Sites in Aurora +23 more locations
Sponsor: Novartis Pharmaceuticals
Sex: Male·Age: 18 - 100
Code: NCT05803941·Phase 4·Recruiting·Listed Apr 2023
Tempus Small Cell Lung Cancer Observational Study (Sculptor)
for Small Cell Lung Cancer
Sites in Aurora +6 more locations
Sponsor: Tempus AI
Sex: All·Age: 18+
Code: NCT05257551·Recruiting·Listed Feb 2022
Study of mRNA-4359 Administered Alone and in Combination With Immune Checkpoint Blockade in Participants With Advanced Solid Tumors
for Advanced Solid Tumors
Sites in Aurora +13 more locations
Sponsor: ModernaTX, Inc.
Sex: All·Age: 12+
Code: NCT05533697·Phase 1, Phase 2·Recruiting·Listed Sep 2022
A Study Evaluating the Efficacy and Safety of Pirtobrutinib in Participants With Relapsed or Refractory Chronic Lymphocytic Leukemia/Small Lymphocytic Lymphoma
for Chronic Lymphocytic Leukemia
Sites in Aurora +20 more locations
Sponsor: Loxo Oncology, Inc.
Sex: All·Age: 18+
Code: NCT06588478·Phase 2·Recruiting·Listed Sep 2024
Study of Olutasidenib and Temozolomide in HGG
for High Grade Glioma
Sites in Aurora +10 more locations
Sponsor: Rigel Pharmaceuticals
Sex: All·Age: 12 - 39
Code: NCT06161974·Phase 2·Recruiting·Listed Dec 2023
Phase 1 Study of INBRX-109 in Subjects With Locally Advanced or Metastatic Solid Tumors Including Sarcomas
for Ewing Sarcoma
Sites in Aurora +17 more locations
Sponsor: Inhibrx Biosciences, Inc
Sex: All·Age: 12 - 85
Code: NCT03715933·Phase 1·Recruiting·Listed Oct 2018
A Study of Neladalkib (NVL-655) in Patients With Advanced NSCLC and Other Solid Tumors Harboring ALK Rearrangement or Activating ALK Mutation (ALKOVE-1)
for Locally Advanced Solid Tumor
Sites in Aurora +19 more locations
Sponsor: Nuvalent Inc.
Sex: All·Age: 12+
Code: NCT05384626·Phase 1, Phase 2·Recruiting·Listed May 2022
ACTengine® IMA203/IMA203CD8 as Monotherapy or in Combination With Nivolumab in Recurrent and/or Refractory Solid Tumors
for Refractory Cancer
Drug: Nivolumab
Sites in Aurora +12 more locations
Sponsor: Immatics US, Inc.
Sex: All·Age: 18+
Code: NCT03686124·Phase 1, Phase 2·Recruiting·Listed Sep 2018
Open-label Study of BBO-8520 in Adult Subjects With KRASG12C Non-small Cell Lung Cancer
for Non-small Cell Lung Cancer
Sites in Aurora +21 more locations
Sponsor: TheRas, Inc., d/b/a BBOT (BridgeBio Oncology Therapeutics)
Sex: All·Age: 18+
Code: NCT06343402·Phase 1·Recruiting·Listed Apr 2024
A Study of TTI-101 as Monotherapy and in Combination in Participants With Locally Advanced or Metastatic, and Unresectable Hepatocellular Carcinoma
for Hepatocellular Carcinoma
Sites in Aurora +17 more locations
Sponsor: Tvardi Therapeutics, Incorporated
Sex: All·Age: 18+
Code: NCT05440708·Phase 1, Phase 2·Recruiting·Listed Jul 2022
A Study of Revumenib in R/R Leukemias Including Those With an MLL/KMT2A Gene Rearrangement or NPM1 Mutation
for Acute Myeloid Leukemia
Drug: Revumenib
Sites in Aurora +9 more locations
Sponsor: Syndax Pharmaceuticals
Sex: All·Age: 30 Days+
Code: NCT04065399·Phase 1, Phase 2·Recruiting·Listed Aug 2019
A Study of HC-7366 in Combination With Belzutifan (WELIREG™) in Patients With Renal Cell Carcinoma
for Renal Cell Carcinoma
Sites in Aurora, Lone Tree +18 more locations
Sponsor: HiberCell, Inc.
Sex: All·Age: 18+
Code: NCT06234605·Phase 1·Recruiting·Listed Jan 2024
Study of TJ033721 (Givastomig) in Subjects With Advanced or Metastatic Solid Tumors
for Solid Tumor
Drug: Givastomig
Sites in Aurora +5 more locations
Sponsor: I-Mab Biopharma US Limited
Sex: All·Age: 18+
Code: NCT04900818·Phase 1·Recruiting·Listed May 2021
Evaluate BL-B01D1 in Patients With Metastatic or Unresectable Non-Small Cell Lung Cancer (NSCLC) and Other Solid Tumors
for Non Small Cell Lung Cancer
Sites in Aurora +23 more locations
Sponsor: SystImmune Inc.
Sex: All·Age: 18+
Code: NCT05983432·Phase 1·Recruiting·Listed Aug 2023
A Phase 1/3 Study of T-Cell Receptor Engineered Donor T Cells in Subjects Undergoing Allogeneic Peripheral Blood Stem Cell Transplantation
for AML
Sites in Aurora, Denver +19 more locations
Sponsor: TScan Therapeutics, Inc.
Sex: All·Age: 18+
Code: NCT05473910·Phase 1·Recruiting·Listed Jul 2022
A Study of Repotrectinib in Pediatric and Young Adult Subjects Harboring ALK, ROS1, OR NTRK1-3 Alterations
for Locally Advanced Solid Tumors
Drug: Repotrectinib
Sites in Aurora +11 more locations
Sponsor: Turning Point Therapeutics, Inc.
Sex: All·Age: Up to 25
Code: NCT04094610·Phase 1, Phase 2·Recruiting·Listed Sep 2019
Phase 1b Study of OP-1250 (Palazestrant) in Combination With Ribociclib, Alpelisib, Everolimus, or Atirmociclib in ER+, HER2- Breast Cancer
for Metastatic Breast Cancer
Drug: Palazestrant
Sites in Aurora +13 more locations
Sponsor: Olema Pharmaceuticals, Inc.
Sex: All·Age: 18+
Code: NCT05508906·Phase 1·Recruiting·Listed Aug 2022
A Study of NX-1607 in Adults With Advanced Malignancies
for Ovarian Cancer, Epithelial
Sites in Aurora +8 more locations
Sponsor: Nurix Therapeutics, Inc.
Sex: All·Age: 18+
Code: NCT05107674·Phase 1·Recruiting·Listed Nov 2021
Safety, PK, and Preliminary Efficacy of MBRC-101 in Advanced Refractory Solid Tumors
for Cancer
Sites in Aurora +14 more locations
Sponsor: MBrace Therapeutics
Sex: All·Age: 18+
Code: NCT06014658·Phase 1, Phase 2·Recruiting·Listed Aug 2023
A Phase I/II Study of VLS-1488 in Subjects With Advanced Cancer
for Advanced Solid Tumor
Sites in Aurora +12 more locations
Sponsor: Volastra Therapeutics, Inc.
Sex: All·Age: 18+
Code: NCT05902988·Phase 1, Phase 2·Recruiting·Listed Jun 2023
Evaluation of the Safety and Efficacy of Abenacianine (VGT-309) to Identify Cancer in Subjects Undergoing Surgery for Cancer in the Lung
for Lung Cancer
Sites in Aurora +7 more locations
Sponsor: Vergent Bioscience, Inc.
Sex: All·Age: 18+
Code: NCT07499674·Phase 3·Recruiting·Listed Mar 2026
A Phase III Trial of BNT324 Versus Docetaxel in Metastatic Castration-resistant Prostate Cancer
for Metastatic Castration-resistant Prostate Cancer
Sites in Aurora +14 more locations
Sponsor: BioNTech SE
Sex: Male·Age: 18+
Code: NCT07365995·Phase 3·Recruiting·Listed Jan 2026
A Study to Investigate Sonrotoclax (BGB-11417) Plus Zanubrutinib (BGB-3111) Compared With Venetoclax Plus Acalabrutinib in Adults With Previously Untreated Chronic Lymphocytic Leukemia
for Chronic Lymphocytic Leukemia
Drug: Sonrotoclax
Sites in Aurora +12 more locations
Sponsor: BeOne Medicines
Sex: All·Age: 18+
Code: NCT07277231·Phase 3·Recruiting·Listed Dec 2025
Conditions in Oncology (Aurora, CO)
Solid tumor· 31Breast cancer· 25Colorectal cancer· 21Non-small cell lung cancer (NSCLC)· 19Cancer (any)· 16Acute myeloid leukemia (AML)· 14Non-Hodgkin lymphoma· 13Melanoma· 13Ovarian cancer· 11Esophageal cancer· 9Prostate cancer· 9Pancreatic cancer· 8Glioma· 8Hematologic malignancy· 8Neuroblastoma· 8Lung cancer· 7Glioblastoma· 7Leukemia (other)· 7Metastatic breast cancer· 6Kidney cancer· 6Chronic lymphocytic leukemia (CLL)· 6Head and neck cancer· 6Gastric cancer· 5Metastatic prostate cancer· 5Myelodysplastic syndromes (MDS)· 5Triple-negative breast cancer· 4Gastroesophageal junction cancer· 4Endometrial cancer· 4Multiple myeloma· 4Acute lymphoblastic leukemia· 4Hodgkin lymphoma· 4Small cell lung cancer· 3Liver cancer· 3Biliary tract cancer· 3Bladder cancer· 3Cervical cancer· 3Fallopian tube cancer· 3Myelofibrosis· 3Myeloproliferative neoplasm· 3Diffuse large B-cell lymphoma (DLBCL)· 3Thyroid cancer· 3Sarcoma· 3Osteosarcoma· 3Ewing sarcoma· 3HER2-positive breast cancer· 2HER2-negative breast cancer· 2Colon cancer· 2Rectal cancer· 2Gastrointestinal cancer· 2Brain metastases· 2Follicular lymphoma· 2Small lymphocytic lymphoma· 2Burkitt lymphoma· 2Pediatric cancer· 2Neuroendocrine tumors· 2Metastatic colorectal cancer· 1Brain cancer· 1Mantle cell lymphoma· 1Marginal zone lymphoma· 1Skin cancer· 1Rhabdomyosarcoma· 1